125 related articles for article (PubMed ID: 2342073)
1. Substituted vitamin K epoxide analogues. New competitive inhibitors and substrates of vitamin K1 epoxide reductase.
Ryall RP; Nandi DL; Silverman RB
J Med Chem; 1990 Jun; 33(6):1790-7. PubMed ID: 2342073
[TBL] [Abstract][Full Text] [Related]
2. 2-(Fluoromethyl)-3-phytyl-1,4-naphthoquinone and its 2,3-epoxide. Inhibition of vitamin K epoxide reductase.
Silverman RB; Oliver JS
J Med Chem; 1989 Sep; 32(9):2138-41. PubMed ID: 2769684
[TBL] [Abstract][Full Text] [Related]
3. Rat and human liver vitamin K epoxide reductase: inhibition by thiol blockers and vitamin K1.
Wallin R; Patrick SD; Martin LF
Int J Biochem; 1987; 19(11):1063-8. PubMed ID: 3428478
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K epoxide reductase activity in the metabolism of epoxides.
Liptay-Reuter I; Dose K; Guenthner T; Wörner W; Oesch F
Biochem Pharmacol; 1985 Aug; 34(15):2617-20. PubMed ID: 4015704
[TBL] [Abstract][Full Text] [Related]
5. Effect of N-ethylmaleimide on beef and rat liver vitamin K1 epoxide reductase.
Silverman RB; Nandi DL
J Enzyme Inhib; 1990; 3(4):289-94. PubMed ID: 2319331
[TBL] [Abstract][Full Text] [Related]
6. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone.
Mukharji I; Silverman RB
Proc Natl Acad Sci U S A; 1985 May; 82(9):2713-7. PubMed ID: 3857611
[TBL] [Abstract][Full Text] [Related]
7. Characterization and purification of the vitamin K1 2,3 epoxide reductases system from rat liver.
Begent LA; Hill AP; Steventon GB; Hutt AJ; Pallister CJ; Cowell DC
J Pharm Pharmacol; 2001 Apr; 53(4):481-6. PubMed ID: 11341364
[TBL] [Abstract][Full Text] [Related]
8. Vitamin K1 hydroquinone formation catalyzed by a microsomal reductase system.
Fasco MJ; Principe LM
Biochem Biophys Res Commun; 1980 Dec; 97(4):1487-92. PubMed ID: 7213374
[No Abstract] [Full Text] [Related]
9. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats.
Fasco MJ; Preusch PC; Hildebrandt E; Suttie JW
J Biol Chem; 1983 Apr; 258(7):4372-80. PubMed ID: 6833262
[TBL] [Abstract][Full Text] [Related]
10. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
[TBL] [Abstract][Full Text] [Related]
11. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
Creedon KA; Suttie JW
Thromb Res; 1986 Oct; 44(2):147-53. PubMed ID: 3787564
[TBL] [Abstract][Full Text] [Related]
12. Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle.
Guenthner TM; Cai D; Wallin R
Biochem Pharmacol; 1998 Jan; 55(2):169-75. PubMed ID: 9448739
[TBL] [Abstract][Full Text] [Related]
13. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
Preusch PC; Suttie JW
J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
[TBL] [Abstract][Full Text] [Related]
14. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
[TBL] [Abstract][Full Text] [Related]
15. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
Fasco MJ; Principe LM; Walsh WA; Friedman PA
Biochemistry; 1983 Nov; 22(24):5655-60. PubMed ID: 6652076
[TBL] [Abstract][Full Text] [Related]
16. Sulfaquinoxaline inhibition of vitamin K epoxide and quinone reductase.
Preusch PC; Hazelett SE; Lemasters KK
Arch Biochem Biophys; 1989 Feb; 269(1):18-24. PubMed ID: 2916837
[TBL] [Abstract][Full Text] [Related]
17. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
Preusch PC; Suttie JW
Arch Biochem Biophys; 1984 Nov; 234(2):405-12. PubMed ID: 6497379
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase.
Hazelett SE; Preusch PC
Biochem Pharmacol; 1988 Mar; 37(5):929-34. PubMed ID: 3345202
[TBL] [Abstract][Full Text] [Related]
19. A fibroblast cell culture model to study vitamin K metabolism and the inhibition of vitamin K epoxide reductase by known and suspected antagonists.
Ross PJ; Shearer MJ; Diplock AT; Schey SA
Br J Haematol; 1991 Feb; 77(2):195-200. PubMed ID: 2004021
[TBL] [Abstract][Full Text] [Related]
20. B16 tumor cells contain a warfarin sensitive vitamin K1 2,3 epoxide reductase.
Uitendaal MP; Thijssen HH; Drittij-Reijnders MJ; Hoeijmakers MJ
Biochem Biophys Res Commun; 1986 Jun; 137(3):1015-20. PubMed ID: 3729947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
